Approved and Donation Ready
This fund has been developed in response to patients who have contacted PAF for help with their medication expenses and could not find help. While this fund has been fully designed and we are ready to provide needed support to these patient communities, this fund is not yet able to accept applications for assistance as we are still working to secure charitable donations that will allow us to open it.
If you, or someone you know, would like to contribute to this fund, please visit our Donors page for more information on how to provide critical support for patients in need.Fund Type
Co-pay, Co-Insurance & DeductibleMaximum Award Level
$3,000 Per Year
- Household Income Requirements 400% or less of Federal Poverty Guideline (FPG) (adjusted for Cost of Living Index (COLI) and number in household)
- Insurance Requirements All Insurance Types
- Must reside and receive treatment in the United States.
Migraine headache is a complex neurobiological disorder involving nerve pathways and brain chemicals that reflect a genetically induced hypersensitivity involving neurons located within the central nervous system. When a primed neuron is triggered by a change in the external environment (e.g. drop in barometric pressure) or the internal environment (e.g. drop in serotonin or estrogen levels), the neuron induces pathways in the brain to awaken and narrow blood vessels, resulting in a migraine attack. Research shows that the brain – not changes in blood vessels as previously believed – represent the ultimate origin of a migraine.
There are two major types of migraine, Migraine with aura (classic migraine) and Migraine without aura (common migraine). Other types of migraine include: basilar-type migraine, hemiplegic migraine, menstrually-related migraine, migraine without headache, ophthalmoplegic migraine, retinal migraine and status migrainosus. Migraine attacks are often accompanied by disturbing symptoms such as: visual disturbances, nausea, vomiting, dizziness, sensitivity to sound, light, touch and smell and tingling or numbness in the extremities or face.
Migraine is three times more common in women than in men, and is commonly experienced between the ages of 15 and 55, becoming less severe and frequent with age. There is often a family history of migraine or of disabling headaches. Migraine can be episodic, occurring only a few times a year; or chronic, with headaches occurring more than 15 days a month. Untreated attacks generally last between 4 and 72 hours.
- Good Days877-968-7233
- Healthwell Foundation800-675-8416
- Leukemia & Lymphoma Society800-955-4572
- National Organization for Rare Disorders800-999-6673
- Needy Meds800-503-6897
- Patient Access Network Foundation866-316-7263
- Patient Services Inc.800-366-7741
- The Assistance Fund855-845-3663